Trending Now
Immunomedics, Inc. (NASDAQ:IMMU) Expands Its Current Clinical Collaboration with Roche to...
Today, many companies are stepping out of their personalized healthcare strategy to accommodate collaborations. This way, they can advance their research and development efforts....
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Inovio Pharmaceuticals Inc. (NASDAQ:INO) Responds To FDA Questions On Halted Phase...
Inovio Pharmaceuticals Inc. (NASDAQ:INO) has responded to questions from the FDA regarding INO-4800 and the Cellectra vaccine delivery device. The FDA had imposed a...
MAKE IT MODERN
LATEST REVIEWS
CRISPR Therapeutics (NASDAQ:CRSP) Announce Positive Phase 1 CARBON study Results Of...
CRISPR Therapeutics (NASDAQ:CRSP) has released encouraging top-line results from its ongoing Phase 1 CARBON study. The study evaluates the efficacy and safety of its...
MAKE IT MODERN
PERFORMANCE TRAINING
Salarius Pharmaceutical Inc. (NASDAQ:SLRX) Reports Q3 2020 Financial and Updates on Ewing Sarcoma Treatment
Salarius Pharmaceutical Inc. (NASDAQ:SLRX) has announced its financial results and corporate updates for the three months ended September 30, 2020.
Salarious expanded Ewing sarcoma clinical...
Annovis Bio Inc (NYSEAMERICAN: ANVS), Cassava Sciences Inc (NASDAQ: SAVA), Honest Company Inc (NASDAQ:...
Annovis Bio Inc (NYSEAMERICAN: ANVS), Cassava Sciences Inc (NASDAQ: SAVA), Honest Company Inc (NASDAQ: HNST), And Hyzon Motors Inc (NASDAQ: HYZN) are reportedly in...
Titan Pharmaceuticals Inc (NASDAQ: TTNP) Receives FDA Clearance For IND for Phase 1 study...
Titan Pharmaceuticals Inc (NASDAQ: TTNP) has received clearance from the FDA for its Investigational New Drug Application for the Phase 1 study of its...
Agenus (NASDAQ: AGEN) Presents Clinical Data Evaluating AGEN1181 As A Monotherapy or combination with...
Agenus (NASDAQ: AGEN) presented new clinical data for AGEN1181 as a monotherapy and in combination with balstiilimab at the 36th Annual Society of Immunotherapy...
AEterna Zentaris Inc. (NASDAQ: AEZS) Receives a Note of Allowance for AEZS-150
AEterna Zentaris Inc. (NASDAQ: AEZS) announced that the U.S Patent and Trademark Office gave the University of Sheffield, its licensor, an allowance notice after...
MAKE IT MODERN
